Total planned funding: $190,269,628
Allocations
Countries/Regions
Ukraine | $190,269,628 |
Organizational Types
Unknown | $56,054,960 |
NGO | $48,794,702 |
Private Contractor | $30,439,191 |
Own Agency | $24,444,800 |
Multi-lateral Agency | $11,275,607 |
University | $9,399,234 |
Implementing Agency | $5,297,040 |
Other USG Agency | $2,964,094 |
Host Country Government Agency | $1,600,000 |
Program Areas
Governance and Systems | $83,488,972 |
Treatment | $30,688,671 |
Testing | $30,540,072 |
Prevention | $17,857,857 |
Management and Operations | $17,132,778 |
Care | $10,148,578 |
Budget Codes
OHSS: Health Systems Strengthening | $49,041,622 |
HVCT: Testing: HIV Testing and Counseling | $30,540,072 |
HVSI: Strategic Information | $21,662,732 |
HTXS: Treatment: Adult Treatment | $18,283,381 |
HVMS: Management and Operations | $17,132,778 |
HLAB: Laboratory Infrastructure | $12,784,618 |
HTXD: Treatment: ARV Drugs | $12,405,290 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $9,205,489 |
HVOP: Sexual Prevention: Other Sexual Prevention | $6,555,403 |
HVTB: Care: TB/HIV | $6,086,402 |
HBHC: Care: Adult Care and Support | $2,349,094 |
HMBL: Biomedical Prevention: Blood Safety | $2,024,865 |
HKID: Care: Orphans and Vulnerable Children | $1,713,082 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $72,100 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $0 |
Top Partner Programs
Not Available:
$40,834,817
Countries/Regions
USG Aggregated Agencies:
$17,017,414
Countries/Regions
Chemonics International:
$16,719,470
Countries/Regions